×

Download our new e-book. Biosimilars 101: Facts, Risks & Opportunities

Thank you!
Error - something went wrong!
   

Biosimilars 101: Facts, Risks & Opportunities

December 20, 2016

The emergence of biosimilars over the last few years has introduced a new competitive specialty pharmaceuticals market to combat the rising price tags on expensive biologics.

Previous File
Pharmaceutical Costs Remain Major Concern for Healthcare Leaders
Pharmaceutical Costs Remain Major Concern for Healthcare Leaders

Pharmaceutical Costs Remain Major Concern for Healthcare Leaders.

Next File
KLAS Finds Premier Has Highest Overall Performance in Healthcare Management Consulting
KLAS Finds Premier Has Highest Overall Performance in Healthcare Management Consulting

KLAS, an independent healthcare research firm, published a December 2016 report on the market for healthcar...